期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Matrix metalloproteinase 13,a new target for therapy in Alzheimer’s disease
1
作者 Jean-Michel Paumier gopal thinakaran 《Genes & Diseases》 SCIE 2019年第1期1-2,共2页
Alzheimer’s disease(AD),the most common neurodegenerative disorder,affects millions of people worldwide.In a recent publication,Guo-Jun Chen and colleagues highlight the role of matrix metalloproteinase(MMP)13(also c... Alzheimer’s disease(AD),the most common neurodegenerative disorder,affects millions of people worldwide.In a recent publication,Guo-Jun Chen and colleagues highlight the role of matrix metalloproteinase(MMP)13(also called Collagenase 3)in AD pathogenesis through regulating BACE1,1 a rate-limiting enzyme for b-amyloid(Ab)peptide production.2 Proteolytic processing of amyloid precursor protein(APP)by BACE1 and g-secretase generates Ab,which accumulate in brain senile plaques in AD.3 MMPs are a group of enzymes that degrade extracellular matrix and cleave proteins involved in signal transduction. 展开更多
关键词 Alzheimer’s disease BACE1 eIF4B MMP MMP13 PI3K signaling
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部